Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Centers for Autism and Developmental Disabilities Research and Epidemiology, A Case Cohort Study. Request for Applications (RFA) Number DD06-003, 25175 [E6-6417]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 82 / Friday, April 28, 2006 / Notices
Idaho, and thereby engage in
nonbanking financial and investment
advisory services, pursuant to sections
225.28(b)(6)(i) and (b)(7)(i) of Regulation
Y.
Board of Governors of the Federal Reserve
System, April 24, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–6372 Filed 4–27–06; 8:45 am]
Dated: April 21, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–6417 Filed 4–27–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6210–01–S
Centers for Medicare & Medicaid
Services
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: CMS–216, CMS–
10191, and CMS–588]
Centers for Disease Control and
Prevention
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Centers for
Autism and Developmental Disabilities
Research and Epidemiology, A Case
Cohort Study. Request for
Applications (RFA) Number DD06–003
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Centers for Autism and
Developmental Disabilities Research and
Epidemiology (CADDRE), A Case Cohort
Study.
Time and Date: 8 a.m.–5 p.m., June 23,
2006 (Closed).
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Building
19, Room 248, Atlanta, GA 30333.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: To conduct expert
review of scientific and merit of research
applications: Centers for Autism and
Developmental Disabilities Research and
Epidemiology, A Case Cohort Study, RFA–
DD06–003.
jlentini on PROD1PC65 with NOTICES
FOR FURTHER INFORMATION CONTACT:
Juliana Cyril, Ph.D., Scientific Review
Administrator, CDC, 1600 Clifton Road,
NE., Mail Stop D–72, Atlanta, GA,
30333, Telephone 404.639.4897, e-mail
address: zdq4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
VerDate Aug<31>2005
17:14 Apr 27, 2006
Jkt 208001
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Organ
Procurement Organization/
Histocompatibility Laboratory
Statement of Reimbursable Cost, Manual
Instructions and Supporting Regulations
Contained in 42 CFR 413.20 and 413.24;
Use: CMS is requesting reapproval of
Form CMS–216–94 (OMB No. 0938–
0102). The current form implements
various provisions of the Social Security
Act, including section 1881(a) which
provides Medicare coverage for endstage renal disease patients who meet
certain entitlement requirements and
kidney donors. It also implements
sections 1881(b)(2)(B) and 1861(v)(1)(A)
of the Act to determine the reasonable
costs incurred to furnish treatment for
renal patients and transplant patients.
The reasonable costs of securing and
AGENCY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
25175
transporting organs cannot be
determined for the fiscal year until the
Organ Procurement Organization/
Histocompatibility Laboratory files its
cost report (Form CMS–216) at year-end
and costs are verified by the Medicare
fiscal intermediary.; Form Number:
CMS–216 (OMB#: 0938–0102);
Frequency: Recordkeeping—Daily,
Reporting—Annually; Affected Public:
Business or other for-profit, Not-forprofit institutions, and the Federal
government; Number of Respondents:
108; Total Annual Responses: 108; Total
Annual Hours: 4,860.
2. Type of Information Collection
Request: New Collection; Title of
Information Collection: Medicare Part D
Audit Guide, Version 1.0 and
Supporting Regulation contained in 42
CFR Section 423.505; Use: 42 CFR
section 423.505 provides CMS the
regulatory authority to audit, evaluate,
or inspect any Part D sponsors’
performance related to the law in the
areas of medication therapy
management, drug utilization
management, formulary, and grievances
and appeals. The information collected
will be an integral resource for
oversight, monitoring, compliance, and
auditing activities necessary to ensure
quality provision of the Medicare
Prescription Drug Benefit to
beneficiaries.; Form Number: CMS–
10191 (OMB#: 0938-New); Frequency:
Recordkeeping and Reporting—
Annually; Affected Public: Business or
other for-profit; Number of
Respondents: 564; Total Annual
Responses: 564; Total Annual Hours:
54,144.
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Electronic
Funds Transfer Authorization
Agreement; Use: Section 1815(a) of the
Social Security Act provides the
authority for the Secretary of Health and
Human Services to pay providers/
suppliers of Medicare services at such
time or times as the Secretary
determines appropriate (but no less
frequently than monthly). Under
Medicare, CMS, acting for the Secretary,
contracts with fiscal intermediaries and
carriers to pay claims submitted by
providers/suppliers who furnish
services to Medicare beneficiaries.
Under CMS’ payment policy, Medicare
providers/suppliers have the option of
receiving payments electronically. Form
number CMS–588 authorizes the use of
electronic fund transfers (EFTs).; Form
Number: CMS–588 (OMB#: 0938–0626);
Frequency: Recordkeeping and
Reporting—On occasion; Affected
Public: Business or other for-profit, Not-
E:\FR\FM\28APN1.SGM
28APN1
]]>Agencies
[Federal Register Volume 71, Number 82 (Friday, April 28, 2006)]
[Notices]
[Page 25175]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-6417]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panels (SEP): Centers for Autism and Developmental
Disabilities Research and Epidemiology, A Case Cohort Study. Request
for Applications (RFA) Number DD06-003
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Centers for Autism and Developmental
Disabilities Research and Epidemiology (CADDRE), A Case Cohort
Study.
Time and Date: 8 a.m.-5 p.m., June 23, 2006 (Closed).
Place: Centers for Disease Control and Prevention, 1600 Clifton
Road, NE., Building 19, Room 248, Atlanta, GA 30333.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: To conduct expert review of scientific
and merit of research applications: Centers for Autism and
Developmental Disabilities Research and Epidemiology, A Case Cohort
Study, RFA-DD06-003.
FOR FURTHER INFORMATION CONTACT: Juliana Cyril, Ph.D., Scientific
Review Administrator, CDC, 1600 Clifton Road, NE., Mail Stop D-72,
Atlanta, GA, 30333, Telephone 404.639.4897, e-mail address:
zdq4@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 21, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-6417 Filed 4-27-06; 8:45 am]
BILLING CODE 4163-18-P
